A simple and effective diagnostic test for gastrointestinal bleeding to improve patient outcomes
Ended Project Grant Awarded Last action
- Award ID
- R41DK106779
- Recipient
-
Cumberland Pharmaceuticals, Inc. UEI M2ZXA6LYJ3S5
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,999
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Tennessee, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$0 | |
| Amendment | -$0 | |
| Amendment | $0 | |
| Original award | $224,999 |
Quick answers
Who received award R41DK106779?
R41DK106779 was awarded to Cumberland Pharmaceuticals, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 1, 2016.
How much is award R41DK106779 worth?
$224,999 has been obligated on R41DK106779.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award